Genome-wide association studies have revealed multiple NAFLD risk loci5, with a single-nucleotide polymorphism (SNP) in the PNPLA3 gene as one of the strongest links6. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.